Accepted at 3:32 p.m. Jul, 22, 2024 by Ahmed7
Author: cmahlen
Related Note: 1497197947379
Rationale for change

image

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Bootcamp::Genetics::01_DNA_Structure::05_Clinical_Applications_of_the_Pyrimidine_Pathway #AK_Step2_v12::#AMBOSS::RF0l33 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::12_Antimetabolites::*Pyrimidine_Synthesis_Inhibitors::Methotrexate #AK_Step2_v12::#B&B::09_MSK::01_General::01_Arthritis_I::Extra #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#OME_banner #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::10_5-FU_Methotrexate_Leucovorin_Hydroxyurea #AK_Step2_v12::#SketchyIM::07_Rheumatology::Retired_Lessons::02_Systemic_Rheumatic_Diseases::01_Rheumatoid_Arthritis_SOAP_[OLD_VERSION] #AK_Step2_v12::#UWorld::Step::4573 #AK_Step1_v12::^Other::^EXPN #AK_Step1_v12::#B&B::12_Hematology::04_Cancer_Drugs::01_Antimetabolites #AK_Step1_v12::#AMBOSS::M4aMPk #AK_Step1_v12::#B&B::13_Immunology::03_Pharm::02_Immunosuppressive_Drugs #AK_Step1_v12::#AMBOSS::a4aQ3k #AK_Step1_v12::#AMBOSS::3UaS1P #AK_Step1_v12::#UWorld::COMLEX::23830 #AK_Step2_v12::#UWorld::COMLEX::101356 #AK_Step1_v12::#UWorld::COMLEX::24927 #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::01_Antimetabolites::01_Methotrexate,_leucovorin,_5-fluorouracil,_hydroxyurea::zanki_extra #AK_Step1_v12::#UWorld::Step::1818 #AK_Step1_v12::#UWorld::Step::718 #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::10_Cell_Cycle_Dependent_Drug_Targets